Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Biophysics
Reference185 articles.
1. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy;Raja;Semin. Cancer Biol.,2019
2. Nanomedicine in treatment of breast cancer – a challenge to conventional therapy;Afzal;Semin. Cancer Biol.,2019
3. Designing a broad-spectrum integrative approach for cancer prevention and treatment;Block;Semin. Cancer Biol.,2015
4. Ligand-targeted theranostic nanomedicines against cancer;Yao;J. Control. Release,2016
5. An investigative approach to the treatment modalities of squamous cell carcinoma;Akhter;Curr. Drug Deliv.,2017
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vitro and ex vivo evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma;Drug Development and Industrial Pharmacy;2024-07-02
2. Nanoparticle‐Based Drug Delivery Platform for Simultaneous Administration of Phytochemicals and Chemotherapeutics: Emerging Trends in Cancer Management;Particle & Particle Systems Characterization;2024-06-28
3. Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies;Journal of Drug Targeting;2024-05-22
4. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs;Drug Design, Development and Therapy;2024-05
5. Targeting triple negative breast cancer stem cells using nanocarriers;Discover Nano;2024-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3